MMWR. Morbidity and mortality weekly report
-
MMWR Morb. Mortal. Wkly. Rep. · Jan 2013
Emergency department visits and hospitalizations for buprenorphine ingestion by children--United States, 2010-2011.
Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.
-
MMWR Morb. Mortal. Wkly. Rep. · Jan 2013
Obesity prevalence among low-income, preschool-aged children--New York City and Los Angeles County, 2003-2011.
Recent studies have reported evidence of a leveling and decline in childhood obesity prevalence in New York and California. However, some areas of the United States continue to experience increases in the prevalence of childhood obesity. To assess differences and changes over time in early childhood obesity in the two most populous cities in the United States, obesity prevalence among low-income, preschool-aged children enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) in New York City (NYC) was compared with obesity prevalence among WIC-enrolled children in Los Angeles County (LAC) during 2003-2011. ⋯ Hispanic WIC-enrolled children had the greatest prevalence of obesity for all years in both areas. In 2011, the obesity prevalence among Hispanics in NYC was 19.1%, compared with 21.7% in LAC. Comparisons of obesity prevalence data among cities and states might suggest interventions and policies to help reverse childhood obesity increases in some populations.